Fresenius Medical Care | FME - Ebitda



金融业
股票价格
EUR
资产
EUR 31.29B
现金及等价物
EUR 1.06B
销售成本
EUR 3.55B
流动资产
EUR 7.69B
流动负债
EUR 7.18B
债务
EUR 10.96B
股息收益率
3.76
EBIT
EUR 480.55M
EBITDA
EUR 843.66M
员工
112.38K
EPS每股收益
EUR 1.12
股本和储备
EUR 13.53B
销售毛利
EUR 1.31B
债务利息支出
EUR 83M
利息收入
EUR 14.7M
贷款资金
EUR 5.82B
市值
EUR 12.41B
净收入
EUR 218.38M
营业费用
EUR 4.32B
营业利润
EUR 537.27M
普通股股本
EUR 266.11M
PE价格收益
12.13
税前利润
EUR 383M
销售收入
EUR 4.86B
销售和管理费用
EUR 736.01M
股票
EUR 2.33B
贸易债权人
EUR 891.84M
应收帐款人
EUR 3.47B


Ebitda 更改 日
Akzo Nobel EUR 398M 53M 2026-06
Alcon AG USD 795M 478M 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Bayer EUR 2.14B 2.31B 2026-06
Beiersdorf EUR 984M 147M 2025-06
DaVita Healthcare Partners USD 746.81M 86.98M 2026-06
Demant DKK 2.76B 165M 2025-12
E.ON EUR 5.12B 2.28B 2026-03
Essilor EUR 4.34B 1.25B 2026-06
Fresenius EUR 988M 37M 2026-06
Fresenius Medical Care EUR 843.66M 19.66M 2026-06
Genmab DKK 401M 186M 2026-06
Getinge SEK 1.89B 1.58B 2026-06
Givaudan CHF 778M 195M 2025-12
GlaxoSmithKline GBP 3.51B 734M 2026-06
GN Store Nord DKK 491M 136M 2026-03
GRIFOLS EUR 473M 120M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.6B 69M 2026-06
Novartis USD 6.48B 1.19B 2026-06
Philips EUR 910M 343M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
RWE EUR 1.63B 20M 2026-03
Sanofi EUR 3.69B 375M 2026-06
SAP EUR 3.36B 192M 2026-06
Smith & Nephew USD 796M 139M 2025-12